Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cboe Global Markets (CBOE) Research & Development (2016 - 2025)

Historic Research & Development for Cboe Global Markets (CBOE) over the last 17 years, with Q3 2025 value amounting to $26.6 million.

  • Cboe Global Markets' Research & Development rose 431.37% to $26.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $107.4 million, marking a year-over-year increase of 903.55%. This contributed to the annual value of $102.8 million for FY2024, which is 310.93% up from last year.
  • Cboe Global Markets' Research & Development amounted to $26.6 million in Q3 2025, which was up 431.37% from $26.7 million recorded in Q2 2025.
  • Cboe Global Markets' 5-year Research & Development high stood at $28.5 million for Q4 2024, and its period low was $16.2 million during Q2 2021.
  • In the last 5 years, Cboe Global Markets' Research & Development had a median value of $24.2 million in 2023 and averaged $22.4 million.
  • Its Research & Development has fluctuated over the past 5 years, first soared by 5635.36% in 2023, then crashed by 1307.42% in 2024.
  • Cboe Global Markets' Research & Development (Quarter) stood at $16.6 million in 2021, then rose by 28.31% to $21.3 million in 2022, then increased by 13.62% to $24.2 million in 2023, then increased by 17.77% to $28.5 million in 2024, then decreased by 6.67% to $26.6 million in 2025.
  • Its Research & Development stands at $26.6 million for Q3 2025, versus $26.7 million for Q2 2025 and $25.6 million for Q1 2025.